Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01113892 · ClinicalTrials.gov registry record · NA
Study Comparing Synthetic Vascular Grafts in Patients With Peripheral Artery Disease (PAD) Who Require Artery Bypass.
A NA study, sponsored by Maquet Cardiovascular.
- Completed
- Registry status
- NA
- Development phase
- 207
- Enrollment target
NCT01113892: Completed NA study, sponsored by Maquet Cardiovascular.
NCT01113892 is a NA study that has completed, run by Maquet Cardiovascular. The registered enrollment target is 207 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01113892, a NA study, has completed, sponsored by Maquet Cardiovascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 207 participants
- Enrollment target
Study Summary
To demonstrate the patency and safety of vascular grafts: EXXCEL and FUSION Bioline.
Primary Outcome
A graft was considered to have primary patency if it had remained continuously patent (i.e., had continued blood flow through it) from the time of implantation and it had uninterrupted patency with no procedure performed on it, nor a procedure to address disease progression in the adjacent native vessel. Stenosis developing within the graft without remediation or occlusion was not considered a loss of primary patency. Assessed by duplex ultrasound imaging and ankle brachial index (ABI).
Interventions
- DEVICE vascular grafts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2010-05-17 |
| Est. Completion | 2013-06-04 |
| Phase | NA |
What the finished NCT01113892 record still lists
NCT01113892 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which vascular grafts is the first listed.
NCT01113892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01113892 about?
NCT01113892 is a clinical study titled "Study Comparing Synthetic Vascular Grafts in Patients With Peripheral Artery Disease (PAD) Who Require Artery Bypass.". To demonstrate the patency and safety of vascular grafts: EXXCEL and FUSION Bioline.
What is the current status of trial NCT01113892?
This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2010-05-17. Estimated completion is 2013-06-04.
What interventions are being tested in trial NCT01113892?
The interventions under investigation include: vascular grafts (DEVICE).
Who is sponsoring clinical trial NCT01113892?
This trial is sponsored by Maquet Cardiovascular, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01113892's enrollment target sits among peer trials
207 499th of 2000 higher than 1,502 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI